Adjuvant tamoxifen adherence in male patients with breast cancer: An ongoing challenge

Cancer. 2022 Jan 1;128(1):22-24. doi: 10.1002/cncr.33898. Epub 2021 Oct 1.
No abstract available

Keywords: adjuvant endocrine therapy; adjuvant tamoxifen; discontinuing treatment; drug adherence; male breast cancer.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use
  • Breast Neoplasms* / drug therapy
  • Breast Neoplasms, Male* / drug therapy
  • Humans
  • Longitudinal Studies
  • Male
  • Tamoxifen / therapeutic use

Substances

  • Antineoplastic Agents, Hormonal
  • Tamoxifen